The FDA announced on Sept. 4, 2014, that Hospira Inc. voluntarily recalled Bupivacaine HCl Inj., USP, due to the presence of particulate matter. The agency issued recall number D-1588-2014 for the Class II drug.
How to tell if you have it
- Brand: Hospira
- Product: Bupivacaine HCl Injection
- NDC: 0409-1162-02
- Lot code: 37-268-DK
- Expiration date: 1JAN2016
- Quantity: 75,000 vials
The hazard
A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial. The hazard is classified as the presence of particulate matter.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls include a 2017-04-21 Infant Dextrose Injection recall for hair particulates and a 2016-11-01 Fentanyl Injection recall for broken ampule tips. Similar recent recalls of other products include an American Regent Papaverine HCl Injection recall (2026-07-24), a B. Braun Medical Lactated Ringer's Injection recall (2026-08-12), and a GE Healthcare Omnipaque Injection recall (2026-03-24).